Stay updated on Durvalumab and Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.

Latest updates to the Durvalumab and Daratumumab in MM Clinical Trial page
- Check3 days agoChange DetectedThe page now omits the disease term 'Multiple Myeloma' and its genetics-related topics. This reduces the disease context and access to related resources on the study page.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page's related topics under MedlinePlus were reduced, removing the items 'Multiple myeloma' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- The page adds a MedlinePlus Genetics topic: Multiple myeloma. This expands the page’s coverage to include a genetics-focused overview of this blood cancer, highlighting its genetic aspects for readers seeking authoritative medical information.SummaryDifference0.2%

- Check31 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma, reducing access to genetic information about this condition.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page has updated its revision from v3.1.0 to v3.2.0, added a government-status notice about potential delays and operating status, and linked a new MedlinePlus Genetics topic (Multiple myeloma).SummaryDifference3%

- Check45 days agoChange DetectedCore content updated: 'Plasma cell myeloma' replaced with 'Multiple myeloma' and revision updated to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Durvalumab and Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.